Continuous subcutaneous insulin infusion and multiple dose insulin injections in Type 1 diabetic pregnant women: a case–control study

References

• Kitzmiller JL, Block J, Brown F, Catalano P, Conway D, Coustan DR, Gunderson E, Hermann W, Hoffman L, Inturrisi M, et al Managing pre-existing diabetes for pregnancy. Diabetes Care 2008;31:1060–1079.
   PubMed Web of Science ®Google Scholar
• Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR, Siebenhofer A. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus; systemic review and meta-analysis. Diabetologia 2008;51:941–951.
   PubMed Web of Science ®Google Scholar
• Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008;25:765–774.
   PubMed Web of Science ®Google Scholar
• Coustan DR, Reece EA, Sherwin RS, Rudolf MC, Bates SE, Sockin SM, Holford T, Tamborlane WV, et al Randomized clinical trial of the insulin pump vs. intensive conventional therapy in diabetic pregnancies. JAMA 1986;255:631–636.
   PubMed Web of Science ®Google Scholar
• Carta Q, Meriggi E, Trossarelli GF, Catella G, Dal Molin V, Menato G, Gagliari L, Massobrio M, Vitelli A. Continuous subcutaneous insulin infusion versus intensive conventional insulin therapy in type 1 and type 2 diabetic pregnancy. Diabète Métabolisme 1986;12:121–129.
   PubMed Web of Science ®Google Scholar
• Burkart W, Hanker JP, Schneider HP. Complications and foetal outcome in diabetic pregnancy. Intensified conventional versus insulin pump therapy. Gynecol Obstet Invest 1988;26:104–112.
   PubMedGoogle Scholar
• Leveno KJ, Fortunato SJ, Raskin P, Williams ML, Whalley PJ. Continuous subcutaneous insulin infusion during pregnancy. Diabetes Res Clin Pract 1988;4:257–268.
   PubMedGoogle Scholar
• Farrar D, Tuffnell DJ, West J. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev 2007: CD005542.
   PubMedGoogle Scholar
• Mukhopadhyay A, Farrell T, Fraser RB, Ola B, et al Continuous insulin infusion vs. intensive conventional insulin therapy in pregnant diabetic women: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol 2007;197:447–456.
   PubMed Web of Science ®Google Scholar
• Parazzini F, Cortinovis I, Bortulus R, Fedel L, Recarli A. Weight at birth by gestational age in Italy. Human Reprod 1995;10:1852–1863.
   Google Scholar
• Johansen KS, Hod M. Quality development in perinatal care e the OBSQID project. Int J Gynecol Obstet 1999;64:167–172.
   PubMedGoogle Scholar
• Gabbe SG, Holing E, Temple P, Brown ZA. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol 2000;182:1283–1291.
   PubMed Web of Science ®Google Scholar
• Lapolla A, Dalfrà MG, Masin M, Bruttomesso D, Piva I, Crepaldi C, Tortul C, Dalla Barba B, Fedele D. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy. Acta Diabetol 2003;40:143–149.
   PubMed Web of Science ®Google Scholar
• Hieronimus S, Cupelli C, Bongain A, Durand-Réville M, Berthier F, Fénichel P. Pregnancy in type 1 diabetes: insulin pump versus intensified conventional therapy. Gynecol Obstet Fertil 2005;33:389–394.
   PubMedGoogle Scholar
• Gimenez M, Conget I, Nicolau J, Pericot A, Levy I. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study. Acta Diabetol 2007;44:34–37.
   PubMed Web of Science ®Google Scholar
• Cohen O, Keidar N, Simchen M, Weisz B, Dolitsky M, Sivan E. Macrosomia in well controlled CSII treated type 1 diabetic pregnancy. Gynecol Endocrinol 2008;24:611–613.
   PubMed Web of Science ®Google Scholar
• Cypryk K, Kosinski M, Kaminska P, Kozdray T, Lewinski A. Diabetes control and pregnancy outcomes in women with type 1 diabetes treated during pregnancy with continuous subcutaneous insulin infusion or multiple daily insulin injections. Polikie Archiwum Medycyny Wewnetrzne J 2008;118:339–343.
   PubMedGoogle Scholar
• Kernaghan D, Farrell T, Hammond P, Owen P. Foetal growth in women managed with insulin pump therapy compared to conventional insulin. Eur J Obstet Gynecol Reprod Biol 2008;137:47–49.
   PubMedGoogle Scholar
• Bolli GB, Kerr D, Thomas R, Torlone E, Sola-Gazagnes A, Vitacolonna E, Selam JL, Home PD. Comparision of a multiple daily insulin injection regimen (basal once-daily Glargine plus mealtime Lispro) and continous subcutaneous insulin infusion (Lispro) in type 1 diabetes. A randomized open parallel multicentrer study. Diabetes Care 2009;32:1170–1176.
   PubMed Web of Science ®Google Scholar
• Chen R, Ben-Haroush A, Weismann-Brenner A, Melamed N, Hod M, Yogev Y. Level of glycaemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily insulin injections and continuous subcutaneous insulin infusions. Am J Obstet Gynecol 2007;197:404.e1–e5.
   Web of Science ®Google Scholar
• Mosca A, Paleari R, Dalfrà MG, Di Cianni G, Cuccuru I, Pellegrini G, Malloggi L, Bonomo M, Granata S, Cerotti F, et al Reference intervals for hemoglobin A1c in pregnant women: data from an Italian multicenter study. Clin Chem 2006;52:1138–1143.
   PubMed Web of Science ®Google Scholar
• Kerssen A, de Valk HW, Visser GH. Do HbA1c levels and the self-monitoring of blood glucose levels adequately reflect glycaemic control during pregnancy in women with type 1 diabetes mellitus? Diabetologia 2006;49:25–28.
   PubMed Web of Science ®Google Scholar